Am J Clin Oncol

1. RUMMEL KA, Hallemeier CL, Jin Z, Merrell KW, et al
   The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma.
   Am J Clin Oncol. 2026;49:105-112.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
   ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases.
   Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19269.
   

   >> Share

   
   
3. SASSUN R, Larson DW, Sileo A, Sabella G, et al
   ASO Visual Abstract: Do Tumor Deposits Demand More? Association of Chemotherapy Regimen Intensity with Survival Outcomes in N1 Colon Cancer Patients with Tumor Deposits.
   Ann Surg Oncol. 2026 Feb 20. doi: 10.1245/s10434-026-19293.
   

   >> Share

   
   

   
   Anticancer Res

4. LOPES C, Macedo-Silva C, Farinha M, Costa J, et al
   Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care.
   Anticancer Res. 2026;46:1281-1292.
   

   >> Share

   
   
5. MAIMON O, Nisman B, Ben-David I, Kuznetz A, et al
   Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series.
   Anticancer Res. 2026;46:1569-1575.
   

   >> Share

   
   
6. GKEKAS I, Novotny J, Kaprio T, Fabian P, et al
   Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome-associated dMMR Colorectal Cancer.
   Anticancer Res. 2026;46:1489-1496.
   

   >> Share

   
   

   
   BMC Cancer

7. ZHU H, Cai Y, Ke C, Wang H, et al
   Clinical risk factors and survival analysis of postoperative recurrence or metastasis of colorectal cancer.
   BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15779.
   

   >> Share

   
   
8. SAHM SW, Neumann UP, Zahn MO, Schwittay M, et al
   ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancer.
   BMC Cancer. 2026 Feb 25. doi: 10.1186/s12885-026-15753.
   

   >> Share

   
   
9. HUANG M, Qin Y, Yang Q, Chen X, et al
   UHRF2 related to sumoylation : assessment of its role in immune suppression and therapeutic potential in colorectal cancer.
   BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15727.
   

   >> Share

   
   
10. LI G, Qiu X, Xu L, Lu J, et al
    Clinical characteristics and survival outcomes of well-responders following definite comprehensive treatment in locally advanced rectal cancer.
    BMC Cancer. 2025;26:293.
    

    >> Share

    
    

    
    BMC Gastroenterol

11. XU YB, Huang YS, Huang XX, Ning SF, et al
    Prognostic value of the prognostic nutritional index in colorectal cancer: a systematic review and meta-analysis.
    BMC Gastroenterol. 2026 Feb 24. doi: 10.1186/s12876-026-04702.
    

    >> Share

    
    

    
    Br J Cancer

12. REE AH, Bousquet PA, Visnovska T, Luders T, et al
    Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.
    Br J Cancer. 2026 Feb 23. doi: 10.1038/s41416-026-03357.
    

    >> Share

    
    

    
    Dis Colon Rectum

13. SANCHEZ-RODRIGUEZ M, Pastor C, Jimenez-Ruiz J, Dujovne-Lindenbaum P, et al
    D3 Lymph Node Dissection in Right-Sided Colon Cancer: A video Insight into Key Vascular Variations.
    Dis Colon Rectum. 2026 Feb 24. doi: 10.1097/DCR.0000000000004128.
    

    >> Share

    
    

    
    Eur J Cancer

14. GHEDRI A, van der Baan FH, Otten JMMB, Elferink MAG, et al
    Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.
    Eur J Cancer. 2026;237:116588.
    

    >> Share

    
    

    
    Eur J Surg Oncol

15. SLORDAHL KS, Balto A, Guren MG, Wibe A, et al
    Patient reported outcomes after treatment for colon cancer - A nationwide study.
    Eur J Surg Oncol. 2026;52:111481.
    

    >> Share

    
    

    
    Gastroenterology

16. LADABAUM U, Weinberg DS, Castells A
    Can Colonoscopy Still Be Promoted as the Best Choice for Colorectal Cancer Screening?
    Gastroenterology. 2026;170:456-462.
    

    >> Share

    
    
17. SOMMER AK, Te Paske IBAW, Jansen EAM, Gschwind A, et al
    Mutational Landscape of Colorectal Tumors From Individuals With Unexplained Adenomatous or Serrated Colorectal Polyposis.
    Gastroenterology. 2026;170:557-568.
    

    >> Share

    
    

    
    Int J Cancer

18. HOLTHUIJSEN DDB, Rijnhart JJM, van Roekel EH, Bours MJL, et al
    The mediating role of the kynurenine pathway in longitudinal associations between dietary intake and quality of life in colorectal cancer survivors up to 12 months posttreatment.
    Int J Cancer. 2026 Feb 24. doi: 10.1002/ijc.70363.
    

    >> Share

    
    
19. HAN S, Paik A, Park SY, Le Marchand L, et al
    Dairy products and their key nutrients as protective factors against colorectal cancer risk: The Multiethnic Cohort.
    Int J Cancer. 2026 Feb 23. doi: 10.1002/ijc.70385.
    

    >> Share

    
    

    
    Int J Colorectal Dis

20. MORAWSKA I, Pasicz K, Cieszanowski A
    Mapping fibrosis in colorectal liver metastases (CRLM) with gadobenate dimeglumine-enhanced MRI: prognostic implications and imaging biomarkers.
    Int J Colorectal Dis. 2026;41:68.
    

    >> Share

    
    

    
    J Surg Oncol

21. ROTTOLI M, Calini G, Castagna G, Gori A, et al
    Association Between Colorectal Cancer Screening and Survival in Patients Older Than 70 Years: Results of A National Multicenter Retrospective Study.
    J Surg Oncol. 2026 Feb 22. doi: 10.1002/jso.70206.
    

    >> Share

    
    

    
    Mol Ther Oncol

22. LOU E, Foo J, Leder K
    Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future development.
    Mol Ther Oncol. 2026;34:201139.
    

    >> Share

    
    

    
    PLoS One

23. 
    Expression of Concern: A practical approach for colorectal cancer diagnosis based on machine learning.
    PLoS One. 2026;21:e0343787.
    

    >> Share

    
    
24. 
    Retraction: omega3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients.
    PLoS One. 2026;21:e0343572.
    

    >> Share

    
    
25. LIN L, Ying Y, Shu L, Lv X, et al
    Association between different metabolic obesity phenotypes and colorectal adenoma.
    PLoS One. 2026;21:e0343556.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share